|1.||Beeharry, Neil: 1 article (01/2015)|
|2.||Tomkinson, Alan E: 1 article (01/2015)|
|3.||Matsumoto, Yoshihiro: 1 article (01/2015)|
|4.||Ide, Hiroshi: 1 article (01/2015)|
|5.||Whitford, Tracy A: 1 article (01/2015)|
|6.||Rodriguez, Victoria: 1 article (01/2015)|
|7.||Karkoszka, Jerzy: 1 article (05/2003)|
|8.||Gullberg, Bo: 1 article (05/2003)|
|9.||Wallström, Peter: 1 article (05/2003)|
|10.||Janzon, Lars: 1 article (05/2003)|
01/01/2015 - "Here we show that 5-hydroxymethyl-2'-deoxyuridine (hmUdR) synergistically enhances the activity of FU in cell lines derived from solid tumors but not normal tissues. "
05/01/2003 - "Antibodies against 5-hydroxymethyl-2'-deoxyuridine are associated with lifestyle factors and GSTM1 genotype: a report from the Malmö Diet and Cancer cohort."
01/01/1997 - "Curcumin-mediated effects on TPA-induced formation of the oxidized DNA base 5-hydroxymethyl-2'-deoxyuridine (HMdU) and tumor formation were determined. "
05/01/2003 - "Plasma autoantibodies (aAbs) against the oxidized DNA base derivative 5-hydroxymethyl-2'-deoxyuridine (5-HMdU) are potential biomarkers of cancer risk and oxidative stress. "
01/01/1998 - "Serum autoantibodies recognizing 5-hydroxymethyl-2'-deoxyuridine, an oxidized DNA base, as biomarkers of cancer risk in women."
06/01/1988 - "Metabolism, incorporation into DNA, and interactions with 1-beta-D-arabinofuranosylcytosine of 5-hydroxymethyl-2'-deoxyuridine in human promyelocytic leukemia cells (HL-60)."
12/01/1986 - "The toxicity and metabolism of a thymidine analogue, 5-hydroxymethyl-2'-deoxyuridine (5HmdUrd) were studied with human leukemia cells (HL-60) and with human platelets. "
01/01/1985 - "Fifty percent inhibition of cellular proliferation, assessed by incorporation of [U-14C]-L-leucine in vitro, was caused by 1.7-5.8 X 10(-5) incorporation of [U-14C]-L-leucine in vitro, was caused by 1.7-5.8 X 10(-5) M 5-hydroxymethyl-2'-deoxyuridine in seven human leukemia cell lines. "
|3.||Breast Neoplasms (Breast Cancer)
02/15/1996 - "These results indicate that the levels of 5-hydroxymethyl-2'-deoxyuridine in DNA from peripheral nucleated blood may be potentially useful as a marker of breast cancer."
02/15/1996 - "Levels of 5-hydroxymethyl-2'-deoxyuridine in DNA from blood as a marker of breast cancer."
06/01/2000 - "We examined the levels of a hydroxylated thymine residue, 5-hydroxymethyl-2'-deoxyuridine in DNA obtained from the peripheral blood of 26 women with breast cancer and an age-matched group of 29 control women without breast cancer. "
04/01/1996 - "Topical application of caffeic acid phenethyl ester (CAPE), a constituent of the propolis of honeybee hives, to the backs of CD-1 mice previously initiated with 7,12-dimethylbenz[a]anthracene (DMBA) inhibited 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced tumor promotion and the formation of 5-hydroxymethyl-2'-deoxyuridine (HMdU) in epidermal DNA. "
|5.||Melanoma (Melanoma, Malignant)
|1.||DNA (Deoxyribonucleic Acid)
|3.||Biological Markers (Surrogate Marker)
|6.||Proto-Oncogene Proteins c-jun
|9.||Messenger RNA (mRNA)
|10.||Propolis (Bee Bread)